Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Search

Top

Back to Contracts

Supply of Antifungal Pharmaceutical Agents

Active

Federal

Response Deadline10/26/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract involves the manufacture and supply of Tier 2 antifungal pharmaceutical agents for prime contractors supporting Defense Health Agency projects. The selected provider must ensure all products meet FDA and DHA clinical effectiveness standards and coordinate all deliveries through the DOW Prime Vendor Program. Key deliverables include the pharmaceutical agents themselves and the provision of current NDC Price Lists. To be eligible, contractors must maintain an active SAM registration and ensure full TAA compliance in accordance with FAR 52.225-6. The performance of this contract is centered in San Antonio, Texas, under NAICS code 325412. Responses are due by October 26, 2026.

General Info

Supply Tier 2 antifungal agents for DHA projects in San Antonio by October 2026.

Agency

Department Of Defense → Defense Health Agency (dha)

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

San Antonio, TX, 78230, USA

Set-Aside

NONE

Documents

This scope was carved out of HT9402-26-Q-9404.

The full solicitation package (16 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedOct 8

subcontract

Response DeadlineOct 26

Submission deadline

Response Deadline

10/26/2026, 05:00:00 PM UTCin 6 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → Defense Health Agency (dha)

ContactsNo contacts available

OfficeN/A

Organization / AgencyDepartment Of Defense → Defense Health Agency (dha)

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Supplies antifungal pharmaceutical agents for prime contractors on Defense Health Agency (DHA) pharmaceutical procurement projects. Manufactures and supplies Tier 2 Antifungals meeting FDA and DHA clinical effectiveness standards. Coordinates delivery via the DOW Prime Vendor Program and provides NDC Price Lists. Requires TAA compliance per FAR 52.225-6 and active SAM registration. Delivers pharmaceutical agents and pricing documentation.

Similar Contracts

Same NAICS industry code

Supplier of Red Sealing Compound (NSN 8030015650423)

Defense Logistics Agency

POSTED

about 23 hours ago

DEADLINE

Active Pharmaceutical Ingredient (API) Supply

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 23 hours ago

DEADLINE

Benzocaine and Menthol Lozenge Supply

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 23 hours ago

DEADLINE

Supply of Moxifloxacin Hydrochloride Tablets (400 MG)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 23 hours ago

DEADLINE

Supply of Activated Charcoal, Suspension

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 23 hours ago

DEADLINE

Supply of 4% Chlorhexidine Gluconate Surgical Detergent

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 23 hours ago

DEADLINE

Supply of Bupivacaine and Epinephrine Injection

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 23 hours ago

DEADLINE

Isoniazid Tablet Manufacturing

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 23 hours ago

DEADLINE

Tetrahydrozoline Hydrochloride Ophthalmic Solution Supplier

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 23 hours ago

DEADLINE

Supply of Tolnaftate Powder, USP 1%

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 23 hours ago

DEADLINE

DETERGENT, SURGICAL

Solicitation # SPE2DP-27-T-0122

Solicitation SPE2DP-27-T-0122 is a procurement request by the Defense Logistics Agency for surgical detergent containing 4% chlorhexidine gluconate, identified by NSN 6505-01-101-3759. The requirement is for one 8 oz bottle to be delivered FOB Destination to the USNS ABLE TAGOS 20. The item is FDA regulated and must have a total shelf life of 24 months, with at least 21 months remaining upon delivery to the government. The original required delivery date is October 21, 2026, with a delivery lead time of 20 days after award. The contract mandates strict adherence to Medical Marking Standard No. 1C and DLA packaging requirements RP001. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers. If the material is deemed hazardous per FED-STD-313, it must follow TQ requirement IP025; otherwise, it must comply with ASTM D3951. Offerors must submit quotes via DIBBS by October 26, 2026, and provide a Safety Data Sheet meeting 29 CFR 1910.1200(g) prior to award. The procurement is subject to destination inspection under FAR 52.246-2 and incorporates the Buy American Act and HUBZone price evaluation preferences. Invoicing and receiving reports must be processed through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 23 hours ago

DEADLINE

TETRAHYDROZOLINE HYDRO

Solicitation # SPE2DP-27-T-0130

Solicitation SPE2DP-27-T-0130 is a fixed-price contract issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Tetrahydrozoline Hydrochloride Ophthalmic Solution, USP (NSN 6505-00-139-4600). The requirement consists of one bottle of 0.05 percent, 15 ml solution, to be delivered FOB Destination to the Naval Med Readiness Logistics Cmd in Williamsburg, Virginia, with a required delivery date of October 21, 2026. The item is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. The contract mandates strict adherence to commercial packaging standards, requiring sealed unit containers and exterior shipping containers that protect contents from damage. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and preservation must comply with MIL-STD-2073-1E and special packaging instructions MPWN00001. Additionally, the contractor must comply with FDA regulations, the Buy American and Balance of Payments Program, and specific hazardous material labeling requirements under 29 CFR 1910.1200. Inspection and acceptance will occur at the destination point. Invoicing and payment are to be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 23 hours ago

DEADLINE

More opportunities from Department Of Defense → Defense Health Agency (dha)

Same awarding agency

Supply of Hematological Pharmaceutical AgentsThis subcontract involves the manufacture and supply of Tier 2 hematological pharmaceutical agents for prime contractors supporting Defense Health Agency projects. The selected provider must ensure all agents meet specific clinical and cost-effectiveness criteria and coordinate all deliveries through the DOW Prime Vendor Program. Key deliverables include the pharmaceutical agents themselves and the provision of comprehensive NDC Price Lists. To be eligible, contractors must maintain an active SAM registration and ensure full TAA compliance in accordance with FAR 52.225-6. The performance of this contract is centered in San Antonio, Texas, under NAICS code 325412. Responses for this opportunity are due by October 26, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Supply of Oncological Pharmaceutical AgentsThis subcontract involves the manufacture and supply of Tier 2 oncological pharmaceutical agents to support prime contractors on Defense Health Agency projects. The selected provider must ensure all agents meet specific clinical and cost-effectiveness criteria and coordinate all deliveries through the DOW Prime Vendor Program. Key deliverables include the pharmaceutical agents themselves and the provision of detailed NDC Price Lists. To be eligible, contractors must maintain an active SAM registration and ensure full TAA compliance in accordance with FAR 52.225-6. The performance of this contract is centered in San Antonio, Texas, under NAICS code 325412. Responses for this opportunity are due by October 26, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Cold Chain Transport for Biological MaterialsThis subcontract for Cold Chain Transport for Biological Materials supports prime contractors on Defense Health Agency projects. The scope of work involves the temperature-controlled shipping of biological materials to WRAIR in Silver Spring, Maryland. To ensure the integrity of the shipments, the provider must utilize insulated containers with leak-proof secondary and tertiary containment and employ data loggers to maintain a strict temperature range of 2 to 8 degrees Celsius. The contractor is required to adhere strictly to DOT and IATA shipping regulations for biological substances to ensure all units are delivered without leaks or temperature excursions. This opportunity falls under NAICS code 484220 and is associated with the Department of Defense.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

DEADLINE

Supply of Defibrinated Rabbit BloodThis subcontract involves the supply of defibrinated rabbit blood to prime contractors supporting projects for the Defense Health Agency within the Department of Defense. The scope of work includes the collection of rabbit blood, the defibrination process to meet specific requirements, and the bottling of the product into 50ml units. To ensure quality and traceability, the provider must generate lot numbers and product data sheets for every unit produced. The execution of this contract requires the use of biological processing equipment and laboratory-grade bottling facilities. The total deliverable consists of 48 units of defibrinated rabbit blood per period of performance, with the place of performance located in Silver Spring, Maryland. This opportunity falls under NAICS code 325414 and is associated with a response deadline of October 23, 2026.

Biological Product (except Diagnostic) Manufacturing

POSTED

DEADLINE

PANDHA-26-P-0000 046638 Defibrinated Rabbit Blood

Solicitation # PANDHA-26-P-0000_046638

The Defense Health Agency Contracting Activity, acting on behalf of the Walter Reed Army Institute of Research, intends to award a sole source contract to Lampire Biological Labs, Inc. under FAR 6.302 for the procurement of defibrinated rabbit blood. The requirement is categorized under NAICS code 325414 for Biological Product Manufacturing. The contract structure consists of a base year followed by four one-year option periods, with a delivery requirement of 48 units per period of performance, where each unit is defined as one 50ml bottle. The contractor must ensure each unit is provided with a lot number and an associated product data sheet. Strict packaging and shipping standards are required to prevent leaks, spillage, and damage, while maintaining a temperature range of 2 to 8 degrees Celsius upon arrival at the destination in Silver Spring, Maryland. This procurement is being handled as a presolicitation notice of intent to sole source, with a response deadline for capability statements set for October 23, 2026.

Biological Product (except Diagnostic) Manufacturing

POSTED

DEADLINE

Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program

Solicitation # HT9402-26-Q-9404

The Defense Health Agency, acting for the Department of War, is soliciting quotes under solicitation HT9402-26-Q-9404 to establish Uniform Formulary Blanket Purchase Agreements and Uniform Formulary Additional Discount Program agreements. This procurement is mandated by 10 U.S.C. 1074g to create an integrated pharmacy benefits program for the Military Health System, covering Military Treatment Facilities, the TRICARE Mail Order Pharmacy, and the Basic Core Formulary. The Pharmacy and Therapeutics Committee will evaluate pharmaceutical agents based on relative clinical effectiveness and cost effectiveness to determine their placement on the Uniform Formulary. Specifically, the November 2026 review includes twelve newly approved drugs across various classes, including oncological agents, antifungals, and insulins. Interested manufacturers must submit quotes by October 26, 2026, and provide detailed clinical data regarding the advantages and therapeutic placement of their drugs. Key requirements include maintaining active SAM.gov registration, ensuring Trade Agreements Act compliance via FAR 52.225-6, and agreeing to utilize the Department of War Prime Vendor Program for distribution. The agreement also requires opening limited distribution channels to Accred for mail order services. Award decisions are based on the combined evaluation of clinical and cost effectiveness, with the TRICARE retail network utilization accrual beginning upon the Contracting Officer's signature. The contract allows for termination by either party with 120 days written notice.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

DHA Enterprise-Wide Commercial Solutions Opening (CSO)

Solicitation # HT003826SC005

The Defense Health Agency (DHA) has established the Enterprise-Wide Commercial Solutions Opening (CSO), solicitation number HT003826SC005, to identify and acquire commercial products, services, and non-developmental items. Active from August 7, 2026, through August 6, 2027, this initiative seeks commercially available capabilities that can be deployed immediately or modified to meet DHA requirements across its Medical Digital Solutions, Medical Services, and Medical Products portfolios. The government will utilize a variety of award vehicles, including firm-fixed-price FAR-based contracts and Other Transaction (OT) agreements for research, prototyping, and experimental purposes under authorities such as 10 U.S.C. 3458, 3201, 4021, 4022, and 4023. The procurement process is driven by the issuance of specific Areas of Interest (AoI), which define problem statements, objectives, and submission criteria. Submissions undergo a streamlined, multi-phase evaluation process: Phase I involves a pitch or white paper evaluated on a Go/No-Go basis for strategic alignment and feasibility; Phase II may include an optional oral presentation or demonstration to assess technical viability; and Phase III requires a full commercial proposal evaluated on technical merit, cost reasonableness, and past performance. This CSO is administered by the DHACA Defense Healthcare Management Systems Contracting Division and is designed to prioritize cost-effective, commercially viable solutions to enhance healthcare readiness and patient safety.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Certified Sterile Processing Technician StaffingThis subcontract opportunity involves providing qualified personnel to prime contractors supporting Defense Health Agency projects. The selected provider will supply technicians to execute sterile processing workflows within offsite facilities, specifically focusing on decontamination, assembly, and sterilization processes. Additionally, the scope includes providing staff for inventory management and quality control verification to ensure operational standards are met. Personnel must hold a Certified Registered Central Service Technician (CRCST) designation or an equivalent certification to be eligible. The work is associated with NAICS code 561320 and will be performed in Falls Church, Virginia. Interested parties should note the response deadline of October 30, 2026.

Temporary Help Services

POSTED

DEADLINE

Medical Instrument Courier and Transportation ServicesThis subcontract for Medical Instrument Courier and Transportation Services supports prime contractors on Defense Health Agency projects within the Department of Defense. The service provider is responsible for the scheduled pickup of contaminated surgical instruments from Military Treatment Facilities, secure transport to offsite processing facilities, and the subsequent delivery of sterilized trays back to the facilities. All operations must be conducted using vehicles specifically equipped for biohazardous material transport. The contractor is required to maintain strict chain of custody protocols and ensure full DOT compliance for the handling of medical waste. Performance of these secure transport services is centered in Falls Church, Virginia. Interested parties should note the response deadline of October 30, 2026, for this opportunity categorized under NAICS code 562112.

Hazardous Waste Collection

POSTED

DEADLINE

Offsite Sterile Processing and Sterilization ServicesThis subcontract opportunity for Offsite Sterile Processing and Sterilization Services supports prime contractors on Defense Health Agency projects. The selected provider will be responsible for the complete sterile processing of surgical instruments, including decontamination, assembly, packaging, and sterilization using industry-standard methods. The scope of work specifically includes the handling of specialized equipment such as power equipment, Da Vinci accessories, and minimally invasive surgical cases to ensure all trays are verified and ready for use. To qualify, the contractor must maintain their own Sterile Processing Facilities. The performance of these services is centered in Falls Church, Virginia, under NAICS code 621511. Interested parties must submit their responses by October 30, 2026, to provide these essential medical support services for the Department of Defense.

Medical Laboratories

POSTED

DEADLINE

DHA - Offsite Sterile Processing Support Services

Solicitation # HT9427-27-RFI-0001

The Defense Health Agency (DHA) is issuing a Request for Information (RFI) to identify qualified contractors capable of providing offsite Sterile Processing (SP) support for various Military Treatment Facilities (MTFs) across eight DHA networks. This initiative is part of a Business Case Analysis to improve service resilience and workload stability, ensuring that surgical capabilities are not halted by onsite equipment failures. The scope of work involves the transportation of surgical instruments between MTFs and contractor-owned offsite facilities, where the contractor will provide the necessary personnel, equipment, and facilities to perform decontamination, assembly, sterilization, inventory verification, and quality control. The equipment to be processed includes specialized items such as minimally invasive surgical cases, Da Vinci accessories, and power equipment, with an estimated volume of approximately 2,000 trays monthly per participating MTF. This RFI is strictly for market research and planning purposes and does not constitute a formal solicitation or an obligation to award a contract. The DHA is seeking capability statements from healthcare companies and hospitals that detail their experience with similar projects over the last five years and their proposed implementation strategy. Responses must be submitted in PDF format to the designated Contract Specialist by 11:00 AM EDT on October 30, 2026, and are limited to 10 pages using a 12-point font. The government has not yet determined if a small business set-aside is appropriate and will use the information gathered from these responses to make that decision.

Packaging and Labeling Services

POSTED

DEADLINE

Medical Product SupplierThis subcontract opportunity with the Defense Health Agency under the Department of Defense involves the supply of commercial medical products, devices, and non-developmental items for prime contractors. The scope includes providing off-the-shelf medical consumables and hardware, modifying commercial products to meet specific clinical requirements, and delivering physical prototypes for operational feasibility testing. The contract requires strict adherence to FDA approvals and FAR Part 12 compliance. Performance will be centered in Falls Church, Virginia, under NAICS code 423450. The primary objective is to ensure the delivery of medical hardware and supplies that meet the rigorous standards of the Defense Health Agency.

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS